Indian Journal of Otolaryngology and Head & Neck Surgery, published by SPRINGER INDIA, is a pivotal platform for researchers, practitioners, and students in the field of otolaryngology. With an ISSN of 2231-3796 and an E-ISSN of 0973-7707, this journal aims to disseminate cutting-edge research, innovative techniques, and surgical developments related to head and neck surgery. Recognized for its contributions, it holds a Q3 ranking in both Otorhinolaryngology and Surgery as per the 2023 category quartiles, demonstrating its relevance among the medical community. The journal, which has continually published since 1993, addresses a wide range of topics including clinical studies, surgical techniques, and research advancements, fostering knowledge that informs practice and enhances patient care. By being indexed in Scopus with notable rankings and percentiles, Indian Journal of Otolaryngology and Head & Neck Surgery serves as an essential resource for emerging research and development in this specialized field.

Chirurgie is a prominent academic journal published by Springer Heidelberg, dedicated to advancing the field of surgery through comprehensive research and scholarly discourse. With an ISSN of 2731-6971 and E-ISSN 2731-698X, this journal serves a global community of researchers, surgeons, and medical professionals. Based in Germany, at Tiergartenstraße 17, D-69121 Heidelberg, it plays a crucial role in disseminating high-quality research, evidenced by its categorization in the 2023 Q3 Surgery quartile and ranking within the 41st percentile among 551 journals in the field of Medicine _ Surgery. Although it is not an open access journal, Chirurgie offers vital insights and innovative studies for those committed to enhancing surgical practices and outcomes. The journal's scope encompasses a wide range of surgical disciplines, aiming to publish original research, clinical studies, and review articles that push the boundaries of surgical knowledge and technique.

International Journal of Colorectal Disease is a prestigious peer-reviewed journal published by Springer that focuses on the evolving landscape of colorectal diseases. Established in 1986, this journal has served as a vital platform for researchers, healthcare professionals, and students to explore groundbreaking research, innovative treatment methodologies, and the latest advancements in gastroenterology. With an impressive impact factor and ranked in the Q2 category of gastroenterology by Scopus, it holds a prominent position in the academic community, currently occupying the 59th rank among 167 journals in the field, corresponding to the 64th percentile. Although it does not offer open access, the journal remains invaluable for those seeking in-depth analysis and comprehensive insights into colorectal health issues. As it continues through its convergence years until 2024, the International Journal of Colorectal Disease invites contributions that aim to bridge the gap between research and clinical practice, fostering a deeper understanding of colorectal disorders and enhancing patient care.

Pancreatology is a prestigious journal published by ELSEVIER, focusing on the multifaceted disciplines of endocrinology, diabetes, gastroenterology, and hepatology since its inception in 2001. With an impressive Q1 ranking in multiple categories, including Endocrinology and Gastroenterology, Pancreatology stands out as a critical platform for disseminating peer-reviewed research that contributes to the evolving understanding of pancreatic diseases and associated metabolic disorders. This journal has gained significant recognition in the academic community, underscored by its robust Scopus rankings, positioning it favorably among its peers. While it currently does not offer open access, Pancreatology remains committed to advancing knowledge through high-quality publications and fostering innovation in clinical practice and research. Researchers, professionals, and students are invited to engage with the cutting-edge findings within its pages, which are essential for driving progress in this essential area of medicine.

ACTA OTO-LARYNGOLOGICA is a prestigious academic journal focusing on the field of otorhinolaryngology, published by Taylor & Francis Ltd in the United Kingdom. With an ISSN of 0001-6489 and E-ISSN 1651-2251, this journal has been a cornerstone in the dissemination of research in otolaryngology since its inception in 1918. It maintains a solid impact factor in the scholarly community, categorized in 2023 as Q3 in Medicine (miscellaneous) and Q2 specifically in Otorhinolaryngology, indicating its significance and quality of published work. Researchers and practitioners benefit from comprehensive articles that offer insights and advancements in clinical practices, surgical techniques, and emerging trends in the field. Though it follows a subscription model, ACTA OTO-LARYNGOLOGICA strives to remain accessible for professionals seeking the latest research findings that can enhance patient care and clinical decision-making. By fostering a platform for quality scholarship, the journal plays an essential role in advancing the science and practice of otorhinolaryngology, making it invaluable for researchers, medical professionals, and students alike.

Clinical Genitourinary Cancer, published by CIG MEDIA GROUP, LP, is a leading journal in the fields of Oncology and Urology, with an impressive impact reflected in its quartile rankings (Q2 in Oncology and Q1 in Urology for 2023) and strong Scopus rankings (22nd in Urology and 162nd in Oncology). The journal aims to innovate and inspire new research in genitourinary malignancies, providing a platform for the latest findings in diagnosis, treatment, and patient management. With its commitment to high-quality publications since its establishment in 2005, Clinical Genitourinary Cancer serves a crucial role in advancing the understanding of these complex conditions and enhancing clinical practices. Researchers, professionals, and students in the medical community are encouraged to engage with this essential resource, which facilitates open access to pioneering studies that drive the field forward.

Gynecologic Oncology, an esteemed journal published by Academic Press Inc Elsevier Science, stands at the forefront of research in the domains of Obstetrics and Gynecology and Oncology. With an exceptional track record dating from 1972 to 2024, this journal has established itself as a vital resource for scholars and practitioners alike, boasting a remarkable Q1 ranking in both fields as of 2023. Gynecologic Oncology not only ranks #13 out of 209 in Obstetrics and Gynecology and #72 out of 404 in Oncology but also operates within the top percentiles of academic influence, with a 94th percentile in Obstetrics and Gynecology and an 82nd percentile in Oncology on Scopus. Although the journal does not currently offer open access, it remains crucial for disseminating original research, reviews, and advances in the management and treatment of gynecological cancers. Researchers and health professionals will find this journal indispensable for staying informed on the latest advancements and breakthroughs in this vital area of medicine, fostering a deeper understanding and potentially transforming patient care practices.

ENT-EAR NOSE & THROAT JOURNAL is a leading platform for the dissemination of high-quality research and clinical insights in the field of otorhinolaryngology and related medical specialties. Published by SAGE PUBLICATIONS INC, the journal has established its significance within the academic community, evidenced by its Q3 ranking in both the Medicine (miscellaneous) and Otorhinolaryngology categories as of 2023, alongside a Scopus rank of #47 out of 123. Since its transition to Open Access in 2019, the journal has further broadened its reach, allowing researchers, professionals, and students to access a wealth of knowledge without financial barriers. With a continual focus on innovative findings and clinical practices from 1976 to 2024, ENT-EAR NOSE & THROAT JOURNAL aims to foster collaboration and enhance understanding in the multifaceted realm of ear, nose, and throat disorders, making it an invaluable resource in both academia and clinical practice. The journal is based in the United States, with its headquarters located at 2455 Teller Rd, Thousand Oaks, CA 91320.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, published by BMJ PUBLISHING GROUP, is a leading interdisciplinary journal focused on advancing research and clinical practice in the field of gynecological oncology. With an ISSN of 1048-891X and an E-ISSN of 1525-1438, the journal has established itself as a vital resource since its inception in 1991, covering cutting-edge advancements through 2024 and beyond. The journal holds esteemed rankings, including Q1 in Obstetrics and Gynecology and Q2 in Oncology, highlighting its influence and high citation impact within the medical community. Its Scopus rankings underscore its prominence, placing it among the top 13% of journals in Obstetrics and Gynecology and the top 27% in Oncology. Although it does not currently offer Open Access options, the journal provides a platform for researchers, clinicians, and students to share significant findings and developments that shape the future of gynecological cancer research and treatment. The INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER stands as a significant pillar in the ongoing effort to improve patient outcomes and foster innovation in this critical area of healthcare.

Uroonkoloji Bulteni-Bulletin of Urooncology, an esteemed journal in the field of uro-oncology, is published by GALENOS PUBL HOUSE and has been committed to advancing the understanding and treatment of genitourinary cancers since its inception in 2002. Emphasizing an open-access model, this journal ensures that valuable research and findings are universally accessible, fostering collaboration and innovation among researchers, practitioners, and students in the medical community. With a focus on disseminating high-quality, peer-reviewed articles, Uroonkoloji Bulteni plays a pivotal role in shaping practices and policies within the uro-oncology domain. The journal covers groundbreaking studies, reviews, and case reports that empower professionals to enhance patient care and improve treatment outcomes. Based in Istanbul, Turkey, the journal is not only a vital resource for regional researchers but also maintains a global reach, contributing to the worldwide discourse in uro-oncology.